Company intelligence / Profile preview

Twogene

Bangkok, Bangkok, Thailandtwogene.com ↗

Ownership: Private
Development stage: Commercial

Overview

Twogene is an active Thailand-based CDMO specializing in the rapid, GMP-compliant production of plasmid DNA and recombinant proteins. Its facilities support research-grade to large-scale GMP-grade batches suitable for gene therapy and vaccine companies. The company enables R&D through commercial stages but does not itself sponsor clinical trials or develop proprietary therapeutics.

Modalities: Plasmid DNARecombinant proteinGene therapy enabling technologiesCell therapy enabling technologies (as CDMO)
Industry: Contract Manufacturing Organization

Partnerships

King Mongkut’s University of Technology Thonburi (KMUTT) – long-term lease/collaboration on National Biopharmaceutical Facility for microbial/cell culture production platforms

Beyond the preview

Go deeper on Twogene.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Twogene.

Explore the full profile